Bright Minds Biosciences INC Form 4 insider transactions
Insider transactions: buys and sells by directors, officers and ten percent owners, filed within two business days of the trade.
NASDAQ
Cormorant Asset Management, LP reported the sale of 109,331 common shares of Bright Minds Biosciences Inc. at a price of $89.50 per share.
NASDAQ
Cormorant Asset Management, LP reports the acquisition of 184,331 common shares of Bright Minds Biosciences Inc. at $21.7 per share, increasing its total indirect holdings to 1,059,331 shares.
NASDAQ
Cormorant Asset Management, LP reports increased ownership in Bright Minds Biosciences Inc. through a series of open market purchases.